BMS-Cellares CAR-T Pact Highlights U.S.-China Biopharma Tensions
Pictured: U.S. and Chinese flags in concrete, broken in the middle/iStock, ffikretow This week’s $380 million collaboration between Bristol Myers Squibb and contract drug manufacturing organization Cellares is ostensibly about securing capacity for …